Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart Program
Picard Medical, Inc., parent company of SynCardia Systems, announced the publication of an independent commentary in Artificial Organs journal discussing its next-generation Emperor Total Artificial Heart platform. The commentary highlights successful acute large-animal implant studies demonstrating the device's stable circulatory support and physi…